Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease
Saulsberry A, Partanen M, Porter J, Podila P, Hodges J, King A, Wang W, Zhao X, Kang G, Jacola L, Hankins J. Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease. Blood 2019, 134: 519. DOI: 10.1182/blood-2019-121617.Peer-Reviewed Original ResearchSickle cell diseaseEconomic Hardship IndexSt. Jude Children's Research HospitalLast paediatric visitAdult careFurther clinical developmentResearch HospitalCare retentionAmbulatory servicesPediatric visitsCell diseaseClinical developmentExact testFirst adult visitSickle Cell ResearchPatients' cognitive levelAdult-centered careFisher's exact testLong latency periodWilcoxon rank sum testChi-square testNeurocognitive screening batteryGene therapyRank sum testAgios Pharmaceuticals